General description
ATC codes
Medicine type
Biological agent
EML status history
First added in 2025
(TRS
1064)
for
Other specified malignant neoplasms of bronchus or lung
Application rejected in 2025
(TRS
1064)
for
Adenocarcinoma of stomach
Added in 2025
(TRS
1064)
for
Other specified malignant neoplasms of bronchus or lung
Therapeutic equivalent for
Wikipedia
DrugBank
Recommendations
Section
Immunomodulators
- Parenteral > General injections > IV: 50 mg per mL in 7 mL vial concentrate for solution for infusion